Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2021

01-12-2021 | Ritonavir | Case report

Ritonavir/tacrolimus interaction

Various toxicities: case report

Published in: Reactions Weekly | Issue 1/2021

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
  • * Drug interaction
…
Literature
Metadata
Title
Ritonavir/tacrolimus interaction
Various toxicities: case report
Publication date
01-12-2021
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2021
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-021-06698-9

Other articles of this Issue 1/2021

Reactions Weekly 1/2021 Go to the issue

Case report

Tadalafil

Case report

Mycophenolate/tacrolimus/valganciclovir

Case report

Ciclosporin/linezolid

Clinical study

Risk-benefit of AstraZeneca COVID-19 vaccination in Australia

Case report

Ruxolitinib

Case report

Bendroflumethiazide/sacubitril/valsartan